Fulvestrant-Palbociclib vs Letrozole-Palbociclib as Initial Therapy for Endocrine-Sensitive, Hormone Receptor–Positive, ERBB2-Negative Advanced Breast Cancer: A Randomized Clinical Trial.

Details

Language :

English

ISSN :

23742437

Volume :

7

Issue :

12

Database :

Complementary Index

Journal :

JAMA Oncology

Publication Type :

Academic Journal

Accession number :

154193495

Full Text :

https://doi.org/10.1001/jamaoncol.2021.4301